PerkinElmer to Acquire EUROIMMUN for Approximately $1.3 Billion

News   Jun 19, 2017

 
PerkinElmer to Acquire EUROIMMUN for Approximately $1.3 Billion
 
 
 
 

RELATED ARTICLES

Long-read Genome Sequencing Used for First Time in a Patient

News

Stanford scientists have used a next-generation technology called long-read sequencing to diagnose a patient’s rare genetic condition that current technology failed to diagnose.

READ MORE

Biological Fingerprint of Tuberculosis Meningitis Discovered in Children

News

Children with tuberculosis meningitis have a biological fingerprint that can be used to assess the severity of the condition, help decide the best course of treatment, and provide clues for novel treatments.

READ MORE

Exosomes Offer Significant Potential in Detecting and Treating Disease

News

Exosomes - tiny biological nanoparticles which transfer information between cells - offer significant potential in detecting and treating disease, the most comprehensive overview so far of research in the field has concluded.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Cell Science Diagnostics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE